MHRA-100547-PIP01-22-M02 (update)

Key Facts

PIPS Key Facts
Active Substance	Active Substance: PEGINTERFERON BETA-1A
Invented Name	Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy Plegridy
PIP Number	MHRA-100547-PIP01-22-M02 (update)
Pharmaceutical form(s)	Pharmaceutical form(s): Solution for injection
Therapeutic area	Therapeutic area: Neurology
Conditions / Indications	Conditions / Indications: Treatment of multiple sclerosis.
Route(s) of administration	Route(s) of administration: SUBCUTANEOUS USE INTRAMUSCULAR USE
PIP applicant	Biogen Idec Limited Country United Kingdom Tel +447394573874 Email kathryn.goodey@biogen.com
Decision Type	Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan.
Compliance Check	Compliance Check Yes
Compliance Check Decision Date	Compliance opinion date 24/07/2025
Compliance Check Procedure Number	Compliance procedure number MHRA-100547-PIP01-22-M02-C

Decision Document

PIPS Decision Documents
Decision Document	Decision Document on a Paediatric Investigation Plan (PIP):PEGINTERFERON BETA-1A.pdf
Published Date	01/05/2026